Get started
WINNER MEDICAL COWW

WINNER MEDICAL CO

45.18CNYD
−0.30−0.66%
As of today at 01:52 GMT
CNY
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

300888 fundamentals

Key facts

Market capitalization‪26.48 B‬CNY
Dividend yield (indicated)0.00%
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−1.71CNY
Founded2000
Employees (FY)‪13.01 K‬
CEOJian Quan Li
Websitewinnermedical.com
About

Winner Medical Co., Ltd. engages in the manufacture and sale of disposable wound-care and surgical products. Its products include medical dressings, wound care, infection protection, disease control, disinfection and cleaning, consumer goods for healthy living, non-woven sanitary napkins and wipes, textiles for infants and adults, and cotton spunlace fabrics. The company was founded by Jian Quan Li on August 24, 2000 and is headquartered in Shenzhen, China.

Ownership
‪‪576.37 M‬‬
Free Float shares
‪‪415.59 M‬‬ (72.1%)
Closely held shares
‪‪160.78 M‬‬ (27.9%)
Free Float shares
‪‪415.59 M‬‬ (72.1%)
Closely held shares
‪‪160.78 M‬‬ (27.9%)
Capital structure
Market cap
‪‪26.48 B‬‬
Debt
‪‪3.20 B‬‬
Minority interest
‪‪718.43 M‬‬
Cash & equivalents
‪‪5.71 B‬‬
Enterprise value
‪‪24.69 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪26.48 B‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
3.22x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
3.22x
Valuation ratios
‪0.00‬
‪0.70‬
‪1.40‬
‪2.10‬
‪2.80‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪13.00‬
‪26.00‬
‪39.00‬
‪52.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−90%‬
‪−45%‬
‪0%‬
‪45%‬
‪90%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−2.20 B‬‬
‪‪−1.10 B‬‬
‪0.00‬
‪‪1.10 B‬‬
‪‪2.20 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪550.00 M‬‬
‪‪1.10 B‬‬
‪‪1.65 B‬‬
‪‪2.20 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪550.00 M‬‬
‪‪1.10 B‬‬
‪‪1.65 B‬‬
‪‪2.20 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Health Consumer Goods
Medical Supplies
By country
Period: 2023
China
Overseas

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪600.00 M‬‬
‪‪1.20 B‬‬
‪‪1.80 B‬‬
‪‪2.40 B‬‬
Actual
Earnings
Next:Apr 29, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪−2.70‬
‪−1.80‬
‪−0.90‬
‪0.00‬
‪0.90‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
−52.49%
Payout ratio (TTM)
Dividend yield TTM
1.98%
Last payment
0.40
Last ex-date
Sep 30, 2024
Dividend history
‪1.00%‬
‪1.25%‬
‪1.50%‬
‪1.75%‬
‪2.00%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.35‬
‪0.70‬
‪1.05‬
‪1.40‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−1.60 B‬‬
‪0.00‬
‪‪1.60 B‬‬
‪‪3.20 B‬‬
‪‪4.80 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪2.50 B‬‬
‪‪5.00 B‬‬
‪‪7.50 B‬‬
‪‪10.00 B‬‬
Assets
Liabilities